If the cardiologists can do it, so can we

Elizabeth DeVita-Raeburn

Michael Sporn believes the best bet for controlling cancer is to pick up the warning signs and nip it in the bud. A pot of gold awaits any drugs company that can come up with a Lipitor for cancer, says Sporn, and easy-to-use biomarkers would already be on the market had one-tenth of the research dollars poured into chemotherapy been invested in proteomics.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.


*


UA-77507851-1